Seegene Continues to Support Israel’s Effort to Manage the Omicron Variant With Timely Delivery of Five Million Tests
- Monday, January 17, 2022, 7:14
- PR Newswire
- Add a comment
SEOUL, South Korea, Jan. 17, 2022 /PRNewswire/ — Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, announced today that it has delivered over five million COVID-19 tests to Israel to help detect and mitigate the spread of the Omicron variant. The company sent…
About the Author
admin has written 21725 stories on this site.